Biomerieux Financials
| BIM Stock | EUR 98.85 0.20 0.20% |
Biomerieux |
Understanding current and past Biomerieux Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Biomerieux's financial statements are interrelated, with each one affecting the others. For example, an increase in Biomerieux's assets may result in an increase in income on the income statement.
Please note, the presentation of Biomerieux's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biomerieux's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Biomerieux's management manipulating its earnings.
Biomerieux Stock Summary
Biomerieux competes with Sartorius Stedim, Eurofins Scientific, Ipsen SA, Edenred SA, and Teleperformance. bioMrieux S.A. provides vitro diagnostic solutions systems for private and hospital laboratories, primarily for the diagnosis of infectious diseases. The company was formerly known as B-D Mrieux. bioMrieux S.A. was founded in 1963 and is based in Marcy lEtoile, France. bioMrieux S.A. is a subsidiary of Institut Mrieux SA. BIOMERIEUX operates under Diagnostics Research classification in France and is traded on Paris Stock Exchange. It employs 11200 people.| Instrument | France Stock View All |
| Exchange | Euronext Paris |
| ISIN | FR0013280286 |
| Business Address | 376 Chemin De |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Benchmark | Dow Jones Industrial |
| Website | www.biomerieux.com |
| Phone | 33 4 78 87 20 00 |
| Currency | EUR - Euro |
You should never invest in Biomerieux without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Biomerieux Stock, because this is throwing your money away. Analyzing the key information contained in Biomerieux's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Biomerieux Key Financial Ratios
Biomerieux's financial ratios allow both analysts and investors to convert raw data from Biomerieux's financial statements into concise, actionable information that can be used to evaluate the performance of Biomerieux over time and compare it to other companies across industries.| Return On Equity | 0.18 | |||
| Return On Asset | 0.1 | |||
| Target Price | 107.8 | |||
| Beta | 0.16 | |||
| Z Score | 18.0 |
Biomerieux Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biomerieux's current stock value. Our valuation model uses many indicators to compare Biomerieux value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biomerieux competition to find correlations between indicators driving Biomerieux's intrinsic value. More Info.Biomerieux SA is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.58 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Biomerieux SA is roughly 1.74 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Biomerieux by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Biomerieux's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Biomerieux SA Systematic Risk
Biomerieux's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Biomerieux volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Biomerieux SA correlated with the market. If Beta is less than 0 Biomerieux generally moves in the opposite direction as compared to the market. If Biomerieux Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Biomerieux SA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Biomerieux is generally in the same direction as the market. If Beta > 1 Biomerieux moves generally in the same direction as, but more than the movement of the benchmark.
Biomerieux December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Biomerieux help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Biomerieux SA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Biomerieux SA based on widely used predictive technical indicators. In general, we focus on analyzing Biomerieux Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biomerieux's daily price indicators and compare them against related drivers.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 8.3 | |||
| Value At Risk | (2.27) | |||
| Potential Upside | 2.28 |
Complementary Tools for Biomerieux Stock analysis
When running Biomerieux's price analysis, check to measure Biomerieux's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomerieux is operating at the current time. Most of Biomerieux's value examination focuses on studying past and present price action to predict the probability of Biomerieux's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomerieux's price. Additionally, you may evaluate how the addition of Biomerieux to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |